# Lassa Fever

Type: pathogen

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/lassa-fever
Canonical HTML page: https://getbiobrief.com/entity/lassa-fever

## Timeline

- **2026-03-16**: NCDC Report — Official confirmation that the death toll has reached 109 fatalities.
- **2026-03-10**: Infection Peak — Weekly new infections begin to show a statistical decline.
- **2026-01-01**: Outbreak Commencement — Start of the 2026 Lassa fever seasonal peak in Nigeria.

## Recent coverage (2 stories)

### Lassa Fever Deaths Hit 214 at 25% CFR: Biopharma Faces Urgent Vaccine & Treatment Demand
2026-07-25 12:11:06 · Sentiment: Strongly negative · Impact: 7/10 · Sources: 2

With 214 deaths and a CFR of 25.0%, the Lassa fever outbreak in Nigeria highlights the critical unmet medical need for vaccines and antivirals. Biotech and pharma companies are strategically positioned to accelerate clinical trials and secure global health funding.
Full story: https://getbiobrief.com/story/lassa-fever-25-pct-cfr-vaccine-development-opportunity

### Nigeria's Lassa Fever Death Toll Reaches 109 Amid Slowing Infection Rates
2026-03-16 15:57:22 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Nigeria's Lassa fever death toll has climbed to 109 in 2026, even as the Nigeria Centre for Disease Control (NCDC) reports a downward trend in new weekly infections. The persistent mortality rate highlights critical gaps in early diagnosis and the urgent need for specialized therapeutics in endemic regions.
Full story: https://getbiobrief.com/story/nigeria-lassa-fever-mortality-ncdc-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.